IGM Biosciences Inc (IGMS)
9.71
+0.01
(+0.10%)
USD |
NASDAQ |
Apr 30, 12:34
IGM Biosciences Shareholders Equity (Quarterly): 203.23M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 203.23M |
| September 30, 2023 | 253.86M |
| June 30, 2023 | 258.61M |
| March 31, 2023 | 239.43M |
| December 31, 2022 | 287.26M |
| September 30, 2022 | 328.18M |
| June 30, 2022 | 375.41M |
| March 31, 2022 | 204.52M |
| December 31, 2021 | 244.91M |
| September 30, 2021 | 285.58M |
| Date | Value |
|---|---|
| June 30, 2021 | 322.46M |
| March 31, 2021 | 355.61M |
| December 31, 2020 | 381.82M |
| September 30, 2020 | 188.18M |
| June 30, 2020 | 206.95M |
| March 31, 2020 | 224.01M |
| December 31, 2019 | 240.23M |
| September 30, 2019 | 254.62M |
| June 30, 2019 | 81.73M |
| December 31, 2018 | -65.83M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
81.73M
Minimum
Jun 2019
381.82M
Maximum
Dec 2020
259.82M
Average
253.86M
Median
Sep 2023
Shareholders Equity (Quarterly) Benchmarks
| Inotiv Inc | 254.16M |
| Synlogic Inc | 42.66M |
| BioXcel Therapeutics Inc | -56.51M |
| Xilio Therapeutics Inc | 36.83M |
| NovaBay Pharmaceuticals Inc | 3.314M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 423.41M |
| Total Liabilities (Quarterly) | 220.18M |
| Current Ratio | 8.182 |